Back to Search
Start Over
Economic Evaluation of anti-epileptic Medicines for Autistic Children with Epilepsy.
- Source :
- Journal of Autism & Developmental Disorders; Jul2024, Vol. 54 Issue 7, p2733-2741, 9p
- Publication Year :
- 2024
-
Abstract
- We examine the cost-effectiveness of treating epilepsy with anti-epileptic medicines in autistic children, looking at impacts on healthcare providers (in England, Ireland, Italy and Spain) and children's families (in Ireland). We find carbamazepine to be the most cost-effective drug to try first in children with newly diagnosed focal seizures. For England and Spain, oxcarbazepine is the most cost-effective treatment when taken as additional treatment for those children whose response to monotherapy is suboptimal. In Ireland and Italy, gabapentin is the most cost-effective option. Our additional scenario analysis presents the aggregate cost to families with autistic children who are being treated for epilepsy: this cost is considerably higher than healthcare provider expenditure. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 01623257
- Volume :
- 54
- Issue :
- 7
- Database :
- Complementary Index
- Journal :
- Journal of Autism & Developmental Disorders
- Publication Type :
- Academic Journal
- Accession number :
- 178677514
- Full Text :
- https://doi.org/10.1007/s10803-023-05941-8